Alterity Therapeutics (ATHE) Other Non Operating Income (2014 - 2025)

Alterity Therapeutics' Other Non Operating Income history runs 11 years deep, the most recent figure standing at $12282.6 for Q4 2025.

• On a quarterly basis, Other Non Operating Income rose 107.28% year-over-year to $12282.6 in Q4 2025; TTM through Dec 2025 was -$449955.0, a 66.67% increase from a year earlier, with the FY2024 full-year figure at -$172.1 billion, up 71.94% from the prior year.
• Other Non Operating Income advanced to $12282.6 in Q4 2025 per ATHE's latest filing, from -$168754.2 in the prior quarter.
• Across five years, Other Non Operating Income topped out at $12282.6 in Q4 2025 and bottomed at -$887856.6 in Q4 2021.
• The 5-year median for Other Non Operating Income is -$168754.2 (2024), against an average of -$267562.3.
• Across the five-year window, Other Non Operating Income tumbled 7673.09% in 2024 and jumped 107.28% in 2025, its largest moves.
• Year by year, Other Non Operating Income stood at -$887856.6 in 2021, then jumped by 66.69% to -$295711.7 in 2022, then surged by 100.75% to $2228.3 in 2023, then tumbled by 7673.09% to -$168754.2 in 2024, then jumped by 107.28% to $12282.6 in 2025.
• Per Business Quant, the three latest ATHE Other Non Operating Income figures stand at $12282.6 (Q4 2025), -$168754.2 (Q4 2024), and $2228.3 (Q4 2023).